课题基金 / 基金详情

TAS::75 0850::TAS RECOVERY ACT ACTNOW CLINICAL TRIAL SUPPORT - CTEP IT Support

TAS::75 0850::TAS RECOVERY ACT ACTNOW CLINICAL TRIAL SUPPORT - CTEP IT Support
TAS::75 0850::TAS 恢复法案 ACTNOW 临床试验支持 - CTEP IT 支持
批准号:
7933246
负责人:
SUDHIR RAJU
金额:
$246.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-02-01 至 2012-01-31
关键词:

项目摘要

项目成果

SUDHIR RAJU的其他基金

相似基金

相关文献

中文摘要
翻译
癌症治疗和诊断部(DCTD)主要通过其癌症治疗评估项目(CTEP),资助了几种独特的机制来开展早期抗癌治疗的开发。这些机制包括许多全国领先的NCI指定的综合癌症中心,NCI的成人和儿童肿瘤合作小组项目,每个州都有参与机构,以及致力于脑癌和儿童癌研究的专业肿瘤联盟。加速新型肿瘤通路临床试验(ACTNOW)项目的重点是通过加快大约30个新的临床治疗试验的发展来加快进展。由于ARRA提供的资源,加速时间表是可能的。ARRA基金将协助NCI工作人员加快这30项临床试验的进度。资金将被添加到CTEP支持合同中,包括癌症治疗和评估项目的信息学和计算机支持合同。
英文摘要
The Division of Cancer Treatment and Diagnosis (DCTD), primarily through its Cancer Therapy Evaluation Program (CTEP), sponsors several unique mechanisms to carry out early anticancer therapy development. The mechanisms encompass many of the nation¿s leading NCI-designated Comprehensive Cancer Centers, NCI¿s Cooperative Group programs in adult and pediatric oncology with participating sites in every state, and specialized Oncology Consortia devoted to the study of brain and childhood cancers. The Accelerating Clinical Trials of Novel Oncologic PathWays (ACTNOW) program is focused on accelerating progress by speeding the development of approximately 30 new clinical treatment trials. The accelerated timeline is possible due to the resources provided by ARRA. ARRA funds will assist NCI staff in supporting the accelerated timeline for mounting these 30 clinical trials. Funds will be added to CTEP support contracts including the Cancer Therapy and Evaluation Program's Informatics and Computer Support Contract. The Cancer Therapy Evaluation Program's Enterprise System (CTEP ESYS) is made up of 22 modules At the present time these modules include but are not limited to: Clinical Trials Monitoring Branch Audit Information System (CTMB-AIS), Protocol Authorization and Tracking System (PATS), Drug Authorization and Review Tracking System (DARTS), Clinical Data Update System (CDUS), Web Enabled CDUS, Common Toxicity Criteria Interactive Tool (CTCAE), Adverse Drug Experience Electronic Reporting Systems (AdEERS), Enterprise Query Wizard (EQW), Financial Instrument and Accrual Tracking System (FIATS), CTEP Account Management System (AMS), Clinical Investigations Branch Information System and Clinical IT (CIBISCIT), Regulatory Affairs Branch Information Tracking System (RABITS), Document Management, Assembly, Review and Tracking System (Docu-MART), and the CTEP Web Page. The primary objectives of the CTEP Enterprise System are to: ¿ Capture data and translate it into a usable format to address the scientific, safety, regulatory and administrative needs of CTEP and the NCI. ¿ Eliminate data redundancy throughout the oncology community ¿ Streamline clinical research operations. ¿ Reduce the administrative burden on NCI staff, contractors, and extramural researchers. ¿ Improve communication between CTEP and its collaborators. ¿ Assure the security and confidentiality of proprietary and patient information. ¿ Increase access to clinical trials to all investigators ¿ Capitalize on XML and other technologies to maximize reusability and integration with other systems in the oncology community. ¿ Support broad patient access to clinical trials. ¿ Expedite the protocol development and review process within both clinical trial organizations and reviewing bodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT
  • 批准号:
    10710563
  • 项目类别:
  • 资助金额:
    $1467.22万
  • 财政年份:
    2022
  • 负责人:
    SUDHIR RAJU
  • 依托单位:
CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT
  • 批准号:
    10849598
  • 项目类别:
  • 资助金额:
    $1754.78万
  • 财政年份:
    2022
  • 负责人:
    SUDHIR RAJU
  • 依托单位:
CTEP-ESYS Support
  • 批准号:
    10361383
  • 项目类别:
  • 资助金额:
    $1955.78万
  • 财政年份:
    2015
  • 负责人:
    SUDHIR RAJU
  • 依托单位:
CTEP-ESYS Support
  • 批准号:
    10170135
  • 项目类别:
  • 资助金额:
    $2065.04万
  • 财政年份:
    2015
  • 负责人:
    SUDHIR RAJU
  • 依托单位:
国内基金
海外基金
ProBDNF/p75NTR轴在肠缺血再灌注损伤中的神经-免疫调控作用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    沈玮云
  • 依托单位:
IP3R/GRP75/VDAC1介导内质网应激—线粒体氧化应激调控慢传输型便秘ICC凋亡的机制及生血通便颗粒的干预作用
FLOT1-GCEVs通过GRP75诱导肝细胞线粒体功能障碍和PMN的形成促进胃癌肝转移的作用及机制研究
  • 批准号:
    2026JJ60297
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王然
  • 依托单位: